Intranasal Lidocaine Spray for Trigeminal Autonomic Cephalgia, Simple and Effective Treatment Modality: A Case Series of Five Patients.

Authors

Aanchal Malik, Jyotsna Punj, Ravinder Kumar Pandey, Dhruv Jain, Vanlal Darlong

Published in

Pain medicine case reports. Volume 10. Issue 5. Pages 439-446.

Abstract

Sphenopalatine ganglion block (SPGB) is a potential treatment option for trigeminal autonomic cephalgia (TAC) performed fluoroscopically or endoscopically. We explored the role of noninvasive SPGB via intranasal application of lidocaine (INL) in hemicrania continua (HC) and probable TAC.
In 4 patients of HC, INL spray decreased baseline acute attacks from Numeric Rating Scale (NRS-11) 8-10/10 to nil acute attacks and baseline continuous NRS-11 from 2-6/10 to 0-2/10 in 3 months. In patient of probable TAC, multiple acute attacks a day of NRS-11 10/10 decreased to NRS-11 1-2/10 in 3 months follow-up, with acute attacks of 1-2 in a day.
Ten percent INL spray may be used as noninvasive treatment modality for HC and probable TAC, both for acute attacks and decreasing basal continuous pain.

PMID:
42550560
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.